State Treasurer State of Michigan cut its holdings in shares of Catalent Inc (NYSE:CTLT) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,800 shares of the company’s stock after selling 1,600 shares during the period. State Treasurer State of Michigan’s holdings in Catalent were worth $1,964,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CTLT. PNC Financial Services Group Inc. grew its stake in Catalent by 111.5% in the second quarter. PNC Financial Services Group Inc. now owns 12,838 shares of the company’s stock worth $451,000 after purchasing an additional 6,768 shares in the last quarter. Advisor Group Inc. grew its stake in Catalent by 1.3% in the second quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock worth $180,000 after purchasing an additional 65 shares in the last quarter. Stifel Financial Corp grew its stake in Catalent by 0.9% in the second quarter. Stifel Financial Corp now owns 10,694 shares of the company’s stock worth $377,000 after purchasing an additional 96 shares in the last quarter. AHL Partners LLP acquired a new position in Catalent in the second quarter worth about $424,000. Finally, Royal Bank of Canada grew its stake in Catalent by 46.7% in the second quarter. Royal Bank of Canada now owns 35,029 shares of the company’s stock worth $1,230,000 after purchasing an additional 11,151 shares in the last quarter. Institutional investors own 99.82% of the company’s stock.

A number of research firms recently commented on CTLT. Royal Bank of Canada set a $48.00 price target on Catalent and gave the stock a “buy” rating in a research note on Monday, February 5th. Stephens downgraded Catalent from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 6th. ValuEngine upgraded Catalent from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. Zacks Investment Research upgraded Catalent from a “hold” rating to a “buy” rating and set a $48.00 price target for the company in a research note on Monday, November 6th. Finally, BidaskClub downgraded Catalent from a “buy” rating to a “hold” rating in a research note on Tuesday, November 14th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Catalent has a consensus rating of “Buy” and a consensus price target of $45.60.

Catalent Inc (CTLT) opened at $40.62 on Tuesday. The company has a quick ratio of 1.78, a current ratio of 2.22 and a debt-to-equity ratio of 2.66. Catalent Inc has a twelve month low of $27.48 and a twelve month high of $47.87. The stock has a market cap of $5,395.41, a PE ratio of 71.26, a price-to-earnings-growth ratio of 2.32 and a beta of 1.47.

Catalent (NYSE:CTLT) last issued its earnings results on Monday, February 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.10. Catalent had a net margin of 3.03% and a return on equity of 23.85%. The firm had revenue of $606.30 million for the quarter, compared to analysts’ expectations of $565.05 million. During the same quarter last year, the company posted $0.27 earnings per share. Catalent’s revenue was up 25.3% on a year-over-year basis. equities analysts expect that Catalent Inc will post 1.53 EPS for the current fiscal year.

In other Catalent news, Director Uwe Roehrhoff bought 7,500 shares of the business’s stock in a transaction on Tuesday, November 21st. The shares were purchased at an average price of $39.22 per share, with a total value of $294,150.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John R. Chiminski sold 181,458 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $39.62, for a total transaction of $7,189,365.96. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

WARNING: This piece of content was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://theolympiareport.com/2018/02/13/catalent-inc-ctlt-stake-decreased-by-state-treasurer-state-of-michigan.html.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).

Institutional Ownership by Quarter for Catalent (NYSE:CTLT)

Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.